Accordingly, in vivo treatment of SLAMF6-knockout cells with TNC-1 did not induce T cell-mediated killing of HNT-34 AML cells (Extended Data Fig. 10g–j). The gene discussed is SLAMF6; the disease is acute myeloid leukemia.